{"cursor":"16414","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| IUPAC_name = image = Enbrel.jpg width = 153\n\n\n| tradename = Enbrel Drugs.com = pregnancy_category = B2 (Au) , B\n| (U.S.) legal_status = S4 (Au) , POM\n| (UK) , â-only (U.S.) routes_of_administration =\n| Subcutaneous\n\n\n| bioavailability = 58â76% (SC) metabolism = Reticuloendothelial system\n| (speculative) elimination_half-life = 70â132 hours excretion =\n\n\n| CAS_number = 185243-69-0 ATC_prefix = L04 ATC_suffix = AB01 PubChemSubstance =\n| 10099 DrugBank = DB00005 UNII_Ref = UNII = OP401G7OJC KEGG = D00742 ChEMBL =\n| 1201572 ChemSpiderID = NA\n\n\n | C=2224 | H=3475 | N=621 | O=698 | S=36 molecular_weight = 51234.9 g/mol\n}} 'Etanercept' (trade name 'Enbrel') is a biopharmaceutical that treats\nautoimmune diseases by interfering with tumor necrosis factor (TNF; a soluble\ninflammatory cytokine) by acting as a TNF inhibitor. It has U.S. F.D.A. approval\nto treat rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque\npsoriasis and ankylosing spondylitis. TNF-alpha is the \"master regulator\" of the\ninflammatory (immune) response in many organ systems. Autoimmune diseases are\ncaused by an overactive immune response. Etanercept has the potential to treat\nthese diseases by inhibiting TNF-alpha.\n\nEtanercept is a fusion protein produced by recombinant DNA. It fuses the TNF\nreceptor to the constant end of the IgG1 antibody. First, the developers\nisolated the DNA sequence that codes the human gene for soluble TNF receptor 2,\nwhich is a receptor that binds to tumor necrosis factor-alpha. Second, they\nisolated the DNA sequence that codes the human gene for the Fc end of\nimmunoglobulin G1 (IgG1). Third, they linked the DNA for TNF receptor 2 to the\nDNA for IgG1 Fc. Finally, they expressed the linked DNA to produce a protein\nthat links the protein for TNF receptor 2 to the protein for IgG1 Fc.\n\nThe prototypic fusion protein was first synthesized and shown to be highly\nactive and unusually stable as a modality for blockade of TNF in vivo in the\nearly 1990s by Bruce A. Beutler, an academic researcher then at the University\nof Texas Southwestern Medical Center at Dallas, and his\ncolleagues. Peppel,K. et al. A tumor necrosis factor (TNF) receptor-IgG\nheavy chain chimeric protein as a bivalent antagonist of TNF activity.\nJ.Exp.Med. 174(6):1483-9, 1991 Peppel,K. et al. Expression of a TNF\ninhibitor in transgenic mice. J.Immunol. 151(10):5699-703,\n1993 Kolls,J. et al. Prolonged and effective blockade of tumor\nnecrosis factor activity through adenovirus-mediated gene transfer.\nProc.Natl.Acad.Sci.USA 91(1):215-9, 1994 These investigators also patented\nthe protein, U.S. Patent number: 5,447,851 selling all rights to its\nuse to Immunex, a biotechnology company that was acquired by Amgen in 2002.\n\nIt is a large molecule, with a molecular weight of 150 kDa., that binds to TNFÎ±\nand decreases its role in disorders involving excess inflammation in humans and\nother animals, including autoimmune diseases such as ankylosing spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic\narthritis, rheumatoid arthritis, and, potentially, in a variety of other\ndisorders mediated by excess TNFÎ±.\n\nIn North America, etanercept is co-marketed by Amgen and Pfizer under the trade\nname Enbrel in two separate formulations, one in powder form, the other as a pre-\nmixed liquid. Wyeth is the sole marketer of Enbrel outside North America\nexcluding Japan where Takeda Pharmaceuticals markets the drug.\n\nEtanercept is an example of a protein-based drug created using the tools of\nbiotechnology and conceived through an understanding afforded by modern\ncell biology.\n","linknr":490,"url":"etanercept","recorded":1376420412,"links":["/w/index.php?title=Etanercept&action=edit","/w/index.php?title=Etanercept&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Etanercept","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/File:Enbrel.jpg","//upload.wikimedia.org/wikipedia/commons/3/3a/Enbrel.jpg","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/etanercept.html","/wiki/Pregnancy_category","/wiki/Australia","/wiki/United_States","/wiki/Regulation_of_therapeutic_goods","/wiki/United_Kingdom","/wiki/Route_of_administration","/wiki/Bioavailability","/wiki/Drug_metabolism","/wiki/Reticuloendothelial","/wiki/Biological_half-life","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=185243-69-0&rn=1","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L04","http://www.whocc.no/atc_ddd_index/?code=L04AB01","/wiki/PubChem","http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=10099","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00005","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=OP401G7OJC","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D00742","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201572","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","/wiki/Biopharmaceutical","/wiki/Tumor_necrosis_factor","/wiki/TNF_inhibitor","/wiki/Rheumatoid","/wiki/Psoriatic_arthritis","/wiki/Ankylosing_spondylitis","/wiki/TNF-alpha","#cite_note-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine-1","/wiki/Fusion_protein","/wiki/Recombinant_DNA","/wiki/CD120","/wiki/Fragment_crystallizable_region","/wiki/Immunoglobulin_G1","/wiki/Bruce_A._Beutler","/wiki/University_of_Texas_Southwestern_Medical_Center_at_Dallas","#cite_note-2","#cite_note-3","#cite_note-4","#cite_note-5","/wiki/Immunex","/wiki/Amgen","#cite_note-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers-6","/wiki/KDa","/wiki/Autoimmune_diseases","/wiki/Ankylosing_spondylitis","#cite_note-pmid17389658-7","/wiki/Juvenile_rheumatoid_arthritis","/wiki/Psoriasis","/wiki/Psoriatic_arthritis","/wiki/Rheumatoid_arthritis","/wiki/Amgen","/wiki/Pfizer","/wiki/Takeda_Pharmaceuticals","/wiki/Protein","/wiki/Biotechnology","/wiki/Cell_biology","#Development","#Mechanism_of_action","#Structure","#Licensed_indications","#Administration","#Safety","#Cost","#Experimental_and_off-label_uses","#Similar_agents","#References","#External_links","/w/index.php?title=Etanercept&action=edit&section=1","/w/index.php?title=Etanercept&veaction=edit&section=1","/wiki/Infliximab","/wiki/Monoclonal_antibody","/wiki/Protein_dimer","#cite_note-pmid11712048-8","/w/index.php?title=Etanercept&action=edit&section=2","/w/index.php?title=Etanercept&veaction=edit&section=2","/wiki/TNF_inhibitor","/wiki/Decoy_receptor","#cite_note-9","/wiki/Cytokine","/wiki/Lymphocyte","/wiki/Macrophage","/wiki/White_blood_cell","/wiki/Inflammation","/wiki/Autoimmune_disease","/wiki/Receptor_(biochemistry)","#cite_note-pmid16135466-10","/w/index.php?title=Etanercept&action=edit&section=3","/w/index.php?title=Etanercept&veaction=edit&section=3","/w/index.php?title=Etanercept&action=edit&section=4","/w/index.php?title=Etanercept&veaction=edit&section=4","/wiki/Rheumatoid_Arthritis","/wiki/Psoriatic_Arthritis","/wiki/Ankylosing_Spondylitis","#cite_note-11","/w/index.php?title=Etanercept&action=edit&section=5","/w/index.php?title=Etanercept&veaction=edit&section=5","/wiki/Freeze_drying","/wiki/Diluent","/wiki/Injection_(medicine)","#cite_note-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System-12","/wiki/Route_of_administration","/wiki/Digestive_system","/w/index.php?title=Etanercept&action=edit&section=6","/w/index.php?title=Etanercept&veaction=edit&section=6","#cite_note-Wyeth_and_Amgen-13","/wiki/Immunosuppressant","#cite_note-titlePrescribing_Information_-_ENBREL-14","/w/index.php?title=Etanercept&action=edit&section=7","/w/index.php?title=Etanercept&veaction=edit&section=7","#cite_note-15","#cite_note-16","#cite_note-17","#cite_note-18","/w/index.php?title=Etanercept&action=edit&section=8","/w/index.php?title=Etanercept&veaction=edit&section=8","#cite_note-19","/wiki/Vasculitis","/wiki/Wegener%27s_granulomatosis","#cite_note-20","/wiki/Alzheimer%27s_disease","#cite_note-pmid16926764-21","#cite_note-tobinick2008-22","#cite_note-23","#cite_note-24","#cite_note-25","/wiki/European_Union","/wiki/Biosimilars","#cite_note-26","#cite_note-27","#cite_note-28","/w/index.php?title=Etanercept&action=edit&section=9","/w/index.php?title=Etanercept&veaction=edit&section=9","/wiki/Pegsunercept","/wiki/Monoclonal_antibodies","/wiki/Infliximab","/wiki/Adalimumab","/wiki/Certolizumab_pegol","/wiki/Golimumab","/w/index.php?title=Etanercept&action=edit&section=10","/w/index.php?title=Etanercept&veaction=edit&section=10","//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png","//commons.wikimedia.org/wiki/Category:Etanercept","#cite_ref-titleTNF_defined_as_a_therapeutic_target_for_rheumatoid_arthritis_and_other_autoimmune_diseases_-_Nature_Medicine_1-0","http://www.nature.com/nm/journal/v9/n10/full/nm939.html","#cite_ref-2","#cite_ref-3","#cite_ref-4","#cite_ref-5","#cite_ref-title.7C.7C_DukeMedNews_.7C.7C_Arthritis_Drug_Effective_for_Depression_in_Psoriasis_Sufferers_6-0","http://www.dukemednews.org/news/article.php?id=9419","#cite_ref-pmid17389658_7-0","http://rheumatology.oxfordjournals.org/cgi/content/full/46/6/999","/wiki/Rheumatology_(Oxford)","/wiki/Digital_object_identifier","http://dx.doi.org/10.1093%2Frheumatology%2Fkem069","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17389658","#cite_ref-pmid11712048_8-0","http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(01)47789-9","/wiki/J._Am._Acad._Dermatol.","/wiki/Digital_object_identifier","http://dx.doi.org/10.1067%2Fmjd.2001.117725","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11712048","#cite_ref-9","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17641054","#cite_ref-pmid16135466_10-0","http://jco.ascopubs.org/cgi/content/full/23/25/5950","/wiki/Digital_object_identifier","http://dx.doi.org/10.1200%2FJCO.2005.04.127","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16135466","#cite_ref-11","http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01240.html","#cite_ref-titleEnbrel_and_Humira_Now_Have_Automated_Delivery_System_12-0","http://www.hopkins-arthritis.org/arthritis-news/2006/automated_delivery.html","#cite_ref-Wyeth_and_Amgen_13-0","http://web.archive.org/web/20080505133653/http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm","http://money.cnn.com/news/newsfeeds/articles/apwire/21965cf0a650a8b5897142bfcbccb427.htm","#cite_ref-titlePrescribing_Information_-_ENBREL_14-0","http://www.enbrel.com/prescribing-information.jsp","#cite_ref-15","http://www.nytimes.com/2011/11/23/business/amgens-new-enbrel-patent-may-undercut-health-care-plan.html","#cite_ref-16","http://seattletimes.com/html/health/2008120449_drugs18m.html","#cite_ref-17","http://bostonherald.com/news/columnists/view/2011_1103painful_reality","#cite_ref-18","http://www.sec.gov/Archives/edgar/data/78003/000119312511048877/dex13.htm","#cite_ref-19","http://clinicaltrials.gov","#cite_ref-20","http://content.nejm.org/cgi/content/full/352/4/351","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa041884","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15673801","#cite_ref-pmid16926764_21-0","http://www.medscape.com/viewarticle/529176","/wiki/MedGenMed","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1785182","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16926764","#cite_ref-tobinick2008_22-0","http://www.jneuroinflammation.com/content/5/1/2","/wiki/Digital_object_identifier","http://dx.doi.org/10.1186%2F1742-2094-5-2","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2211476","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18184433","#cite_ref-23","http://www.newscientist.com/channel/health/mental-health/mg19926681.600-is-miracle-alzheimers-cure-too-good-to-be-true.html","#cite_ref-24","http://www.uspto.gov/patents/resources/terms/156.html","#cite_ref-25","http://www.burrillreport.com/article-amgen_issued_new_patent_on_ra_drug_enbrel.html","#cite_ref-26","http://www.law.duke.edu/journals/dltr/articles/2008dltr0009.html","#cite_ref-27","http://www.govtrack.us/congress/bill.xpd?bill=h111-1427","#cite_ref-28","http://www.cipla.com/CiplaSite/Media/PDF/News-Archives/Press-Release-Launch-of-first-biosimilar-of-Etanercept-in-India.pdf?ext=.pdf","/w/index.php?title=Etanercept&action=edit&section=11","/w/index.php?title=Etanercept&veaction=edit&section=11","http://www.enbrel.com/","http://www.123wise.net/enbrel.pdf","/wiki/Template:Immunosuppressants","/wiki/Template_talk:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Template:Immunosuppressants&action=edit","/wiki/Immunomodulator","/wiki/Immunosuppressive_drug","/wiki/Immunosuppressant","/wiki/ATC_code_L04","/wiki/Antimetabolite","/wiki/Purine_synthesis_inhibitor","/wiki/Azathioprine","/wiki/Mycophenolic_acid","/wiki/Pyrimidine_synthesis_inhibitor","/wiki/Leflunomide","/wiki/Teriflunomide","/wiki/Antifolate","/wiki/Methotrexate","/wiki/Macrolide","/wiki/Interleukin_2","/wiki/FKBP","/wiki/Cyclophilin","/wiki/Calcineurin","/wiki/Tacrolimus","/wiki/Ciclosporin","/wiki/Pimecrolimus","/wiki/Abetimus","/wiki/Gusperimus","/wiki/Thalidomide","/wiki/Lenalidomide","/wiki/Interleukin_1_receptor_antagonist","/wiki/Anakinra","/wiki/Mammalian_target_of_rapamycin","/wiki/Sirolimus","/wiki/Everolimus","/wiki/Ridaforolimus","/wiki/Temsirolimus","/wiki/Umirolimus","/wiki/Zotarolimus","/wiki/Antibody","/wiki/Monoclonal_antibodies","/wiki/Complement_component_5","/wiki/Eculizumab","/wiki/TNF_inhibitor","/wiki/Adalimumab","/wiki/Afelimomab","/wiki/Certolizumab_pegol","/wiki/Golimumab","/wiki/Infliximab","/wiki/Nerelimomab","/wiki/Interleukin_5","/wiki/Mepolizumab","/wiki/Immunoglobulin_E","/wiki/Omalizumab","/wiki/Interferon","/wiki/Faralimomab","/wiki/Interleukin_6","/wiki/Elsilimomab","/wiki/Interleukin_12","/wiki/Interleukin_23","/wiki/Lebrikizumab","/wiki/Ustekinumab","/wiki/CD3_(immunology)","/wiki/Muromonab-CD3","/wiki/Otelixizumab","/wiki/Teplizumab","/wiki/Visilizumab","/wiki/CD4","/wiki/Clenoliximab","/wiki/Keliximab","/wiki/Zanolimumab","/wiki/CD11a","/wiki/Efalizumab","/wiki/CD18","/wiki/Erlizumab","/wiki/CD20","/wiki/Afutuzumab","/wiki/Rituximab","/wiki/Ocrelizumab","/wiki/Pascolizumab","/wiki/CD23","/wiki/Gomiliximab","/wiki/Lumiliximab","/wiki/CD40_(protein)","/wiki/Teneliximab","/wiki/Toralizumab","/wiki/L-selectin","/wiki/Aselizumab","/wiki/CD80","/wiki/Galiximab","/wiki/Basigin","/wiki/Gavilimomab","/wiki/CD154","/wiki/Ruplizumab","/wiki/Belimumab","/wiki/CTLA-4","/wiki/Ipilimumab","/wiki/Tremelimumab","/wiki/Chloramphenicol_acetyltransferase","/wiki/Bertilimumab","/wiki/Lerdelimumab","/wiki/Metelimumab","/wiki/Integrin","/wiki/Natalizumab","/wiki/Interleukin-6_receptor","/wiki/Tocilizumab","/wiki/Lymphocyte_function-associated_antigen_1","/wiki/Odulimomab","/wiki/IL-2_receptor","/wiki/Basiliximab","/wiki/Daclizumab","/wiki/Inolimomab","/wiki/T_cell","/wiki/Zolimomab_aritox","/wiki/Atorolimumab","/wiki/Cedelizumab","/wiki/Fontolizumab","/wiki/Maslimomab","/wiki/Morolimumab","/wiki/Pexelizumab","/wiki/Reslizumab","/wiki/Rovelizumab","/wiki/Siplizumab","/wiki/Talizumab","/wiki/Telimomab_aritox","/wiki/Vapaliximab","/wiki/Vepalimomab","/wiki/Polyclonal_antibodies","/wiki/Anti-thymocyte_globulin","/wiki/Anti-lymphocyte_globulin","/wiki/Fusion_protein","/wiki/CTLA-4","/wiki/Abatacept","/wiki/Belatacept","/wiki/TNF_inhibitor","/wiki/Pegsunercept","/wiki/Aflibercept","/wiki/Alefacept","/wiki/Rilonacept","/wiki/Template:Medicine_navs","/wiki/Lymphocyte","/wiki/Template:Lymphocytes","/wiki/Template:Lymphocytic_immune_system","/wiki/Template:Autoantigens","/wiki/Template:Autoantibodies","/wiki/Template:Complement_system","/wiki/Template:Immunoglobulin_superfamily_immune_receptors","/wiki/Template:Lymphoid_and_complement_immunodeficiency","/wiki/Template:Immunoproliferative_immunoglobulin_disorders","/wiki/Template:Hypersensitivity_and_autoimmune_diseases","/wiki/Template:Lymphoid_malignancy","/wiki/Template:Immunologic_techniques_and_tests","/wiki/Template:Immunostimulants","/wiki/Template:Immunosuppressants","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Etanercept&oldid=565762406","/wiki/Help:Categories","/wiki/Category:TNF_inhibitors","/wiki/Category:Amgen","/wiki/Category:Recombinant_proteins","/wiki/Category:Immunosuppressants","/wiki/Category:Wyeth","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_containing_unverified_chemical_infoboxes","/wiki/Category:Commons_category_with_local_link_same_as_on_Wikidata","/w/index.php?title=Special:UserLogin&returnto=Etanercept&type=signup","/w/index.php?title=Special:UserLogin&returnto=Etanercept","/wiki/Etanercept","/wiki/Talk:Etanercept","#","/wiki/Etanercept","/w/index.php?title=Etanercept&action=edit","/w/index.php?title=Etanercept&veaction=edit","/w/index.php?title=Etanercept&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Etanercept","/wiki/Special:RecentChangesLinked/Etanercept","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Etanercept&oldid=565762406","/w/index.php?title=Etanercept&action=info","//www.wikidata.org/wiki/Q415343","/w/index.php?title=Special:Cite&page=Etanercept&id=565762406","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Etanercept","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Etanercept&oldid=565762406&writer=rl","/w/index.php?title=Etanercept&printable=yes","//de.wikipedia.org/wiki/Etanercept","//es.wikipedia.org/wiki/Etanercept","//fr.wikipedia.org/wiki/%C3%89tanercept","//it.wikipedia.org/wiki/Etanercept","//nl.wikipedia.org/wiki/Etanercept","//ja.wikipedia.org/wiki/%E3%82%A8%E3%82%BF%E3%83%8D%E3%83%AB%E3%82%BB%E3%83%97%E3%83%88","//pl.wikipedia.org/wiki/Etanercept","//pt.wikipedia.org/wiki/Etanercepte","//ru.wikipedia.org/wiki/%D0%AD%D1%82%D0%B0%D0%BD%D0%B5%D1%80%D1%86%D0%B5%D0%BF%D1%82","//fi.wikipedia.org/wiki/Etanersepti","//sv.wikipedia.org/wiki/Enbrel","//tr.wikipedia.org/wiki/Etanercept","#","//www.wikidata.org/wiki/Q415343#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Etanercept","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biochemistry","medicine"],"pdf":["http://www.cipla.com/CiplaSite/Media/PDF/News-Archives/Press-Release-Launch-of-first-biosimilar-of-Etanercept-in-India.pdf?ext=.pdf","http://www.123wise.net/enbrel.pdf"],"categories":["TNF inhibitors","Amgen","Recombinant proteins","Immunosuppressants","Wyeth"],"headings":["Development","Mechanism of action","Structure","Licensed indications","Administration","Safety","Cost","Experimental and off-label uses","Similar agents","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/3/3a/Enbrel.jpg","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["receptor","biochemistry"],["injection","medicine"]],"members":["receptor","injection"],"related":["Australia","United_States","United_Kingdom","Reticuloendothelial","Biopharmaceutical","Tumor_necrosis_factor","TNF_inhibitor","Rheumatoid","Psoriatic_arthritis","Ankylosing_spondylitis","TNF-alpha","Fusion_protein","Recombinant_DNA","CD120","Fragment_crystallizable_region","Immunoglobulin_G1","Bruce_A._Beutler","University_of_Texas_Southwestern_Medical_Center_at_Dallas","Immunex","Amgen","KDa","Autoimmune_diseases","Ankylosing_spondylitis","Juvenile_rheumatoid_arthritis","Psoriasis","Psoriatic_arthritis","Rheumatoid_arthritis","Amgen","Pfizer","Takeda_Pharmaceuticals","Protein","Biotechnology","Cell_biology","Infliximab","Monoclonal_antibody","Protein_dimer","TNF_inhibitor","Decoy_receptor","Cytokine","Lymphocyte","Macrophage","White_blood_cell","Inflammation","Autoimmune_disease","Receptor_(biochemistry)","Rheumatoid_Arthritis","Psoriatic_Arthritis","Ankylosing_Spondylitis","Freeze_drying","Diluent","Injection_(medicine)","Route_of_administration","Digestive_system","Immunosuppressant","Vasculitis","Wegener's_granulomatosis","Alzheimer's_disease","European_Union","Biosimilars","Pegsunercept","Monoclonal_antibodies","Infliximab","Adalimumab","Certolizumab_pegol","Golimumab"]}